Features of the Flow COVID-19in Patients with Type 2 Diabetes Mellitus
Article Sidebar
Main Article Content
Abstract
Concomitant diabetes mellitus (DM) negatively affects the prognosis of patients with COVID‑19, being associated with high rates of mortality, complications and the need for intensive care [1–3].
Article Details
Section
How to Cite
References
Onder G., Rezza G., Brusaferro S. Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. JAMA 2020; 323(18): 1775–1776, https://doi.org/10.1001/jama.2020.4683.
Guan WJ, Liang WH, Zhao Y., Liang HR, Chen ZS, Li YM,
Liu XQ, Chen RC, Tang CL, Wang T., Ou CQ, Li L., Chen PY,
Sang L., Wang W., Li JF, Li CC, Ou LM, Cheng B., Xiong S., Ni ZY,
Xiang J., Hu Y., Liu L., Shan H., Lei CL, Peng YX, Wei L., Liu Y., Hu YH,
Peng P., Wang JM, Liu JY, Chen Z., Li G., Zheng ZJ, Qiu SQ, Luo J.,
Ye CJ, Zhu SY, Cheng LL, Ye F., Li SY, Zheng JP, Zhang NF,
Zhong NS, He JX; China Medical Treatment Expert Group for CO VID-19. Comorbidity and its impact on 1590 patients with COVID-19 in China: a national analysis. Eur Respir J 2020; 55(5): 2000547, https://doi.org/10.1183/13993003.00547–2020.
Wu Z., McGoogan JM Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA 2020; 323(13): 1239,https://doi.org/10.1001/jama.2020.2648.
Glybochko P.V., Fomin V.V., Avdeev S.N., Moiseev S.V., Yavo-Rovsky A. G., Brovko M. Yu., Umbetova K. T., Aliev V. A., Bulanova E. L., Bondarenko I. B., Volkova O. S., Gainitdinova V. V., Gneusheva T. Yu., Dubrovin K. V., Kapustina V. A., Kraeva V. V., Merzhoeva Z. M., Nuralieva G. S., Nogtev P. V., Panasyuk V. V., Politov M. E., Popov A.M., Popova E.N., Raspopina N.A., Royuk V.V., Sorokin Yu.D., Trushenko N.V., Khalikova E.Yu., Tsareva N. . A., Chikina S. Yu., Chichkova N. V., Akulkina L. A., Bulanov N. M., Ermolova L. A., Zykova A. S., Kitbalyan A. A., Moise- ev A. S., Potapov P. P., Tao E. A., Sholomova V. I., Shchepalina A. A., Yakovleva A. A. Clinical characteristics of 1007 patients with severe SARS-COV-2 pneumonia who needed in respiratory support. Clinical Pharmacology and Therapeutics 2020; 29(2): 21–29, https://doi.org/10.32756/0869–5490–2020–2–21–29.
Glybochko PV, Fomin VV, Avdeev SN, Moiseev SV, Yavorovskiy AG, Brovko M. Yu., Umbetova KT, Aliev VA, Bulanova EL, Bondarenko IB, Volkova OS, Gaynitdinova VV, Gneusheva T. Yu., Dubrovin KV, Kapustina VA, Kraeva VV, Merzhoeva ZM, Nuralieva GS, Nogtev PV, Panasyuk VV, Politov ME, Popov AM, Popova EN, Raspopina NA, Royuk VV, Sorokin Yu.D., Trushenko NV, Khalikova E. Yu ., Tsareva NA, Chikina S. Yu., Chichkova NV, Akulkina LA, Bulanov NM, Ermolova LA, Zykova AS, Kitbalyan AA, Moiseev AS, Potapov PP, Tao EA, Sholomova VI, Shchepalina AA, Yakovleva AA Clinical characteristics of 1007 intensive care unit patients with SARS-COV-2 pneumonia. Klinicheskaya farmakologia i terapia 2020; 29(2): 21–29, https://doi.org/10.32756/0869–5490–2020–2–21–29.
Shestakova M. V., Vikulova OK., Isakov M.A., De-
Dov I. I. Diabetes mellitus and COVID-19: analysis of clinical outcomes according to the diabetes registry of the Russian Federation. Problems of endocrinology 2020; 66(1): 35–46, https://doi.org/10.14341/probl12458. Shestakova M.V., Vikulova OK, Isakov M.A., Dedov II Diabetes and COVID-19: analysis of the clinical outcomes according to the data of the Russian diabetes registry. Problemy endokrinologii 2020; 66(1): 35–46, https://doi. org/10.14341/probl12458.
Li S., Wang J., Zhang B., Li X., Liu Y. Diabetes mellitus and cause-specific mortality: a population-based study. Diabetes Metab J 2019; 43(3): 319–341, https://doi.org/10.4093/dmj.2018.0060.
Pearson-Stuttard J., Blundell S., Harris T., Cook DG, Critch-Ley J. Diabetes and infection: assessing the association with glycemic control in population-based studies. Lancet Diabetes Endocrinol 2016; 4(2): 148–158, https://doi.org/10.1016/s2213–8587(15)00379–4.
Wang A., Zhao W., Xu Z., Gu J. Timely blood glucose management for the outbreak of 2019 novel coronavirus disease (COV ID-19) is urgently needed. Diabetes Res Clin Pract 2020; 162: 108118, https://doi.org/10.1016/j.diabres.2020.108118.
Iqbal A., Prince L.R., Novodvorsky P., Bernjak A., Thom-as MR, Birch L., Lambert D., Kay LJ, Wright FJ, Macdonald IA, Jacques RM, Storey RF, McCrimmon RJ, Francis S., Heller SR, Sabroe I. Effect of hypoglycemia on inflammatory responses and the response to low -dose endotoxemia in humans. J Clin Endocrinol Metab 2019; 104(4): 1187–1199, https://doi.org/10.1210/ jc.2018–01168.
Drucker DJ Coronavirus infections and type 2 diabetes shared pathways with therapeutic implications. Endocr Rev 2020; 41(3): 457–470, https://doi.org/10.1210/endrev/bnaa011.
Mehta P., McAuley D.F., Brown M., Sanchez E., Tattersall R.S.
Manson JJ; HLH Across Specialty Collaboration, UK. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet 2020; 395(10229): 1033–1034, https://doi.org/10.1016/s0140–6736(20)30628–0.
Hodgson K., Morris J., Bridson T., Govan B., Rush C., Keth-eesan N. Immunological mechanisms contributing to the double burden of diabetes and intracellular bacterial infections. Immunol- ogy 2015; 144(2): 171–185, https://doi.org/10.1111/imm.12394.
Kulcsar KA, Coleman CM, Beck SE, Frieman MB Co-morbid diabetes results in immune dysregulation and enhanced disease severity following MERS-CoV infection. JCI Insight 2019; 4(20): e131774, https://doi.org/10.1172/jci.insight.131774.
Chen X., HuW., Ling J., Mo P., Zhang Y., Jiang Q., Ma Z., Cao Q., Deng L., Song S., Zheng R., Gao S., Ke H., Gui X., Lundkvist Å., Li J., Lin-Dahl JF, Xiong Y. Hypertension and diabetes delay the viral clear- ance in COVID-19 patients. medRxiv 2020: 2020.03.22.20040774, https://doi.org/10.1101/2020.03.22.20040774.
Šestan M., Marinović S., Kavazović I., Cekinović Đ., Wueest S.,
Turk Wensveen T., Brizić I., Jonjić S., Konrad D., Wensveen FM, Polić B. Virus-induced interferon-γ causes insulin resistance in skeletal muscle and derails glycemic control in obesity. Immunity 2018; 49(1): 164–177.e6, https://doi.org/10.1016/j.immuni.2018.05.005.